Gene · 10643
Papers3,038
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,038
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The RNA-binding protein Snd1/Tudor-SN regulates hypoxia-responsive gene expression. | FASEB Bioadv | 2023 | 37151849 | PubTator, text mining | PubMed |
| m6A methylation regulates hypoxia-induced pancreatic cancer glycolytic metabolism through ALKBH5-HDAC4-HIF1α positive feedback loop. | Oncogene | 2023 | 37149664 | PubTator, text mining | PubMed |
| The G allele of SNP rs3922 reduces the binding affinity between IGF2BP3 and CXCR5 correlating with a lower antibody production. | Eur J Immunol | 2023 | 37141498 | PubTator, text mining | PubMed |
| Bile duct adenoma and small-sized small duct type intrahepatic cholangiocarcinoma show distinct differences in genetic alterations, expression of IMP3 and EZH2 and stromal and inflammatory components. | Histopathology | 2023 | 37140546 | PubTator, text mining | PubMed |
| RNA methylation pattern and immune microenvironment characteristics mediated by m6A regulator in ischemic stroke. | Front Genet | 2023 | 37139237 | PubTator, text mining | PubMed |
| Downregulated liver-elevated long intergenic noncoding RNA (LINC02428) is a tumor suppressor that blocks KDM5B/IGF2BP1 positive feedback loop in hepatocellular carcinoma. | Cell Death Dis | 2023 | 37137887 | PubTator, text mining | PubMed |
| Circular RNA-mediated ceRNA network was identified in human lung adenocarcinoma by high-throughput sequencing. | Thorac Cancer | 2023 | 37137710 | PubTator, text mining | PubMed |
| Research Progress of m6A RNA Methylation in Skin Diseases. | Biomed Res Int | 2023 | 37124930 | PubTator, text mining | PubMed |
| Role of ferroptosis and its non-coding RNA regulation in hepatocellular carcinoma. | Front Pharmacol | 2023 | 37124203 | PubTator, text mining | PubMed |
| Exosomal circRNAs as promising liquid biopsy biomarkers for glioma. | Front Immunol | 2023 | 37122733 | PubTator, text mining | PubMed |
| The Current Status, Challenges, and Future Potential of Therapeutic Vaccination in Glioblastoma. | Pharmaceutics | 2023 | 37111620 | PubTator, text mining | PubMed |
| Epigenetic Targets and Their Inhibitors in Thyroid Cancer Treatment. | Pharmaceuticals (Basel) | 2023 | 37111316 | PubTator, text mining | PubMed |
| Identification of Metabolism-Related Proteins as Biomarkers of Insulin Resistance and Potential Mechanisms of m6A Modification. | Nutrients | 2023 | 37111057 | PubTator, text mining | PubMed |
| CircZBTB44 promotes renal carcinoma progression by stabilizing HK3 mRNA structure. | Mol Cancer | 2023 | 37106446 | PubTator, text mining | PubMed |
| A desert lncRNA HIDEN regulates human endoderm differentiation via interacting with IMP1 and stabilizing FZD5 mRNA. | Genome Biol | 2023 | 37095549 | PubTator, text mining | PubMed |
| Characterization of the m6A regulator-mediated methylation modification patterns in oral squamous cell carcinoma. | Sci Rep | 2023 | 37095314 | PubTator, text mining | PubMed |
| METTL3 Reduces Oxidative Stress-induced Apoptosis in Presbycusis by Regulating the N6-methyladenosine Level of SIRT1 mRNA. | Neuroscience | 2023 | 37087022 | PubTator, text mining | PubMed |
| Molecular Profiling of 50 734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized Management. | J Clin Endocrinol Metab | 2023 | 37071871 | PubTator, text mining | PubMed |
| The diverse role of RNA methylation in esophageal cancer. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37070847 | PubTator, text mining | PubMed |
| Novel insights into the multifaceted roles of m6A-modified LncRNAs in cancers: biological functions and therapeutic applications. | Biomark Res | 2023 | 37069649 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10643/papers?page=37